Full text
Earnings transcript
Read the complete earnings call transcript.
HSTM
HealthStream, Inc.
$26
0.35
(1.36%)
| Exchange: | NASDAQ |
| Market Cap: | 759.595M |
| Shares Outstanding: | 3.757M |
Delayed data
About The Company
| Sector: | Healthcare | |||||
| Industry: | Medical – Healthcare Information Services | |||||
| CEO: | Robert A. Frist Jr. | |||||
| Full Time Employees: | 1083 | |||||
| Address: |
| |||||
| Website: | https://www.healthstream.com |
HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 279,063 | 291,646 | 304,064 |
| Gross Profit | 184,042 | 193,710 | 196,855 |
| EBITDA | 57,095 | 62,530 | 66,696 |
| Operating Income | 16,019 | 21,287 | 20,236 |
| Net Income | 15,213 | 20,007 | 18,342 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 499,942 | 510,766 | 520,374 |
| Total Liabilities | 159,190 | 151,411 | 166,351 |
| Total Stockholders Equity | 340,752 | 359,355 | 354,023 |
| Total Debt | 20,247 | 20,168 | 14,684 |
| Cash and Cash Equivalents | 40,333 | 59,469 | 36,161 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 63,970 | 57,660 | 63,319 |
| Capital Expenditure | -28,006 | -28,142 | -3,685 |
| Free Cash Flow | 35,964 | 29,518 | 59,634 |
| Net Income | 15,213 | 20,007 | 18,342 |
| Net Change in Cash | -5,690 | 19,136 | -23,308 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 359,606.119 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 362,929.931 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 361,127 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 72,064.481 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 72,730.568 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 72,369.263 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 104,718.206 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 105,686.109 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 105,161.091 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 0 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Record Revenue Performance: HealthStream reported record quarterly revenue of $74.4 million in Q2 2025, as highlighted in the earnings call transcript, reflecting strong top-line growth and operational success in core business segments.
- Positive Financial Metrics: Key metrics such as revenue, gross profit, and net income from the income statements indicate consistent financial health, supported by positive operating cash flow and free cash flow trends from the cash flow statements.
- Stable Workforce and Operations: With data from the company profile showing a significant number of full-time employees and a focused industry presence in healthcare technology, HealthStream demonstrates operational stability and sector-specific expertise.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates HSTM intrinsic value between $14.22 – $26.69 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about HSTM valuation
Is HealthStream, Inc. (HSTM) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for HealthStream, Inc. (HSTM) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is HSTM a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether HSTM trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is HSTM’s P/E ratio?
You can see HSTM’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for HSTM?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is HSTM a good long-term investment?
Whether HSTM fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
HSTM
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
1.36
Trading Metrics:
| Open: | 25.65 | Previous Close: | 25.65 | |
| Day Low: | 25.61 | Day High: | 26.19 | |
| Year Low: | 19.5 | Year High: | 29.63 | |
| Price Avg 50: | 22.45 | Price Avg 200: | 23.83 | |
| Volume: | 189016 | Average Volume: | 274001 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeHSTM full analysis
Welcome to MARKETSNAP’s SWOT analysis for HealthStream, a company that might not be on everyone’s radar but is definitely worth a closer look if you’re hunting for opportunities in the healthcare tech space. I’m thrilled to dive into this one with you today because HealthStream operates in a niche that’s got some serious long-term potential. Let’s break down what this company is about, check out the latest buzz and performance, and then get into the meat of our SWOT analysis…
